Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AEON Biopharma, Inc. | 10%+ Owner | Common Stock, $0.0001 par value per share | 4.18M | Jul 21, 2023 | Direct | ||
AEON Biopharma, Inc. | 10%+ Owner | Common Stock, $0.0001 par value per share | 2.4M | Jul 21, 2023 | Indirect Beneficial Ownership in the 2,400,000 owned by Daewoong Pharmaceutical Co., Ltd | ||
AEON Biopharma, Inc. | 10%+ Owner | Senior Secured Convertible Note | $10M | Apr 12, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AEON | AEON Biopharma, Inc. | Apr 12, 2024 | 1 | $10M | 4/A | Apr 16, 2024 | 10%+ Owner |
AEON | AEON Biopharma, Inc. | Apr 11, 2024 | 1 | $10M | 4 | Apr 12, 2024 | 10%+ Owner |
AEON | AEON Biopharma, Inc. | Mar 24, 2024 | 1 | $5M | 4 | Mar 26, 2024 | 10%+ Owner |
AEON | AEON Biopharma, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 28, 2023 | 10%+ Owner |